Investing
Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries Commence Download the PDF here. This post appeared first on investingnews.com
Connect with us
Hi, what are you looking for?
Find And Funds
- Investing
CONNEQT App Launches in USA as Pulse Deliveries Commence
Eclipse Metals Ltd Progresses Grønnedal Resource Expansion: Analytical Assessment of Historical Drill Core Samples Underway
Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®
Cygnus’ first drill hole returns up to 9.1% Cu outside Resource
Strategic Alliance with Macmahon to Accelerate Redevelopment of Nifty
- Stock
Trump’s exaggerated claim that Pennsylvania has 500,000 fracking jobs
Tucker Carlson says father Trump will give ‘spanking’ at rowdy Georgia rally
A GOP operative accused a monastery of voter fraud. Nuns fought back.
Early voting in Wisconsin slowed by label printing problems
American creating deepfakes targeting Harris works with Russian intel, documents show
- Economy
Hannity reveals what he told Trump after 2020 election loss: ‘Winston Churchill’ return
Department of Justice freezes all civil rights division cases: report
Trump nominates head of his personal security detail, Sean Curran, to lead Secret Service: ‘A Great Patriot’
Trump inauguration performer Gavin DeGraw salutes ‘businessman running largest economy in world’
Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’
- Editor’s Pick
Hundreds of same-sex couples to marry as Thailand’s landmark marriage bill takes effect
UN experts urge Thailand not to deport dozens of Uyghurs to China where they face ‘real risk of torture’
Stranded at the border: Migrants are in limbo after Trump cancels border app appointments
Israel’s West Bank military operation draws lessons from Gaza war, defense minister says
2,000-year-old Greek statue found abandoned in garbage bag
Investing
Eclipse Metals Ltd (ASX: EPM) (Eclipse Metals or the Company) is pleased to update shareholders on recent progress at its Grønnedal prospect, located within...
Investing
Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the...
Investing
The outstanding intersection of 7.3m at 4.2% Cu reveals a potential new lode ~250m from the main deposit; Follow-up downhole EM identifies...
Investing
Saga Metals Corp.’s amended and restated initial public offering (IPO) prospectus dated Aug. 30, 2024, has been filed with and accepted by the TSX...
Investing
(TheNewswire) Mexico is the largest silver producing country in the world and has more primary silver mines than any other country. Peru is the...
Investing
Dynasty Gold Corp. (TSXV: DYG) (FSE: D5G1) (OTC Pink: DGDCF) (‘Dynasty’ or the ‘Company’) is pleased to release assay results for the initial phase...
Investing
(TheNewswire) VANCOUVER, BC, September 23, 2024 Heritage Mining Ltd. (CSE: HML FRA:Y66) (‘ Heritage ‘ or the ‘ Company ‘) is pleased to announce the...
Investing
western copper and gold corporation (‘Western’ or the ‘Company’) (TSX: WRN) (NYSE American: WRN) welcomes the recent announcement by Natural Resources Canada (‘NRCan’), conditionally...
Investing
The US Department of Commerce and US Department of State have announced the inaugural meeting of the International Network of AI Safety Institutes, scheduled...
Investing
Commodities giant BHP (ASX:BHP,NYSE:BHP,LSE:BHP) announced on Wednesday (September 18) that it will partner with the Meewasin Valley Authority on efforts to conserve the Meewasin...
Investing
The S&P/TSX Venture Composite Index (INDEXTSI:JX) gained 35.21 points this week to close at 580.43. Meanwhile, the S&P/TSX Composite Index (INDEXTSI:OSPTX) was up 787.22...
Investing
ChemX Materials (ASX:CMX) (ChemX or the Company), an Australian high purity critical materials company and 100%-owner of the HiPurA® patented process to produce High...
Investing
Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce that the Company’s Phase 2a clinical trial investigating narmafotinib in the...